12 studies found for:    "West Nile Fever"
Show Display Options
Rank Status Study
1 Terminated
Has Results
Treatment of West Nile Virus With MGAWN1
Conditions: West Nile Neuroinvasive Disease;   West Nile Virus Infection;   Encephalitis;   Meningitis;   Acute Flaccid Paralysis;   West Nile Fever
Interventions: Biological: MGAWN1;   Biological: Placebo - normal saline
2 Terminated An Exploratory Study of AVI-4020 in Patients With Possible Acute Neuroinvasive West Nile Virus (WNV) Disease
Condition: West Nile Fever
Intervention: Drug: AVI-4020 Injection
3 No longer available Expanded Access to MGAWN1 in Subjects With Suspected West Nile Neuroinvasive Disease; Suspected West Nile Virus Infection; or Substantial Accidental Exposure
Condition: West Nile Virus Infection
Intervention: Biological: MGAWN1
4 Completed Phase I Study of West Nile Virus Vaccine
Condition: West Nile Fever
Intervention: Drug: VRC-WNVDNA020-00-VP
5 Completed Vaccine to Prevent West Nile Virus Disease
Conditions: Healthy;   West Nile Fever;   Healthy Volunteer;   HV
Intervention: Drug: VRC-WNVDNA017-00-VP
6 Completed
Has Results
Safety and Immunogenicity Study of ChimeriVax West Nile Vaccine in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: ChimeriVax-WN02 vaccine;   Biological: Placebo
7 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4delta30) in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: WN/DEN4delta30 vaccine;   Biological: Placebo
8 Completed
Has Results
Safety and Immunogenicity of ChimeriVax-WN02 West Nile Vaccine in Healthy Adults
Condition: West Nile Fever
Interventions: Biological: ChimeriVax-WN02 Low Dose;   Biological: ChimeriVax-WN02 Medium Dose;   Biological: ChimeriVax-WN02 High Dose;   Biological: 0.9% Saline solution;   Biological: 0.9 % NaCl solution
9 Completed Safety of and Immune Response to a West Nile Virus Vaccine (WN/DEN4-3'delta30) in Healthy Adults
Condition: West Nile Fever Encephalitis
Interventions: Biological: WN/DEN4-3'delta30;   Biological: Placebo
10 Completed Natural History of West Nile Virus Infection
Conditions: West Nile Virus;   Encephalitis;   Myelitis
Intervention:
11 Completed West Nile Virus Natural History
Condition: West Nile Virus
Intervention:
12 Recruiting Evaluating the Safety and Immunogenicity of a Live Attenuated West Nile Virus Vaccine for West Nile Encephalitis in Adults 50 to 65 Years of Age
Condition: West Nile Virus
Interventions: Biological: WN/DEN4Δ30 Vaccine;   Biological: Placebo

Indicates status has not been verified in more than two years